北京大学第三医院

What 北京大学第三医院 does

Peking University Third Hospital (北京大学第三医院, "北医三院") is a large-scale tertiary Grade A (三甲) public academic medical center affiliated with Peking University, founded in 1958 and headquartered at 49 Huayuan North Road, Haidian District, Beijing. It operates 6 campuses across Beijing (main campus, Central Party School, Second Outpatient Department, Airport Campus, North Campus, Haidian North Campus) with an estimated 1,000+ beds, providing comprehensive clinical care across internal medicine, surgery, obstetrics/gynecology, pediatrics, and specialized centers including urology, cardiac surgery, thoracic surgery, reproductive medicine, sports medicine, and oncology. The hospital serves as a national referral center for complex and rare diseases, attracting patients from across China through its 100+ member medical consortium network spanning 20+ provinces.

Name

北京大学第三医院

Legal name

北京大学第三医院

Website

https://puh3.net.cn

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

251–500 employees

Short description

Peking University Third Hospital is a top-tier public tertiary academic medical center in Beijing affiliated with Peking University, operating 6 campuses with 1,000+ beds and delivering comprehensive specialty care, robotic surgery, reproductive medicine, and national referrals for complex cases.

Ownership category

akta.pro rank

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Medical services revenue: Public medical institution revenue from outpatient and inpatient medical services, including consultation fees, surgical fees, procedure fees, examination and diagnostic fees, and inpatient ward charges. Revenue is regulated under Beijing's public hospital pricing system and medical insurance framework.
2. Pharmaceutical dispensing: Revenue from dispensing prescribed medications to outpatients and inpatients through the hospital pharmacy.
3. Medical examination and diagnostic services: Revenue from laboratory tests, imaging services (CT, MRI, ultrasound, PET), pathology, and other diagnostic services.
4. Internet hospital and special needs medical services: Revenue from internet hospital (telemedicine) services, night special needs outpatient clinics, and international medical services.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Peking University Third Hospital is a large-scale public tertiary (Class III Grade A) academic medical center providing comprehensive clinical care, medical education, and scientific research across multiple specialties including urology, cardiac surgery, thoracic surgery, reproductive medicine, sports medicine, and oncology. The hospital operates six campuses across Beijing with 1,000+ beds and offers advanced robotic-assisted surgery, minimally invasive procedures, internet hospital telemedicine services, multi-disciplinary treatment, and international medical services. It serves as a national referral center for complex and rare diseases with a medical consortium network of 100+ member hospitals.

Product overview

北京大学第三医院 is a large-scale tertiary hospital providing comprehensive medical services through multiple departments and specialized centers. The hospital operates a digital service ecosystem including internet hospital (互联网医院) for cloud consultations, multi-disciplinary diagnosis and treatment (MDT), international medical services, and rare disease clinics. The facility offers patient-facing digital services such as appointment registration (预约挂号), laboratory and examination result inquiries (检验查询/检查查询), and drug information queries. The hospital is equipped with advanced medical technology including Da Vinci robotic surgical systems for minimally invasive procedures, laser prostate surgery, and various specialized diagnostic and therapeutic services across internal medicine, surgery, and medical technology departments.

Differentiator

Problem solved

Functional benefit

Brands

• 互联网医院: 北医三院互联网医院提供线上诊疗、云诊室入口等数字医疗服务
• 北医三院APP

Products and services

• Internet Hospital (互联网医院) Online hospital service providing cloud consultation entrance and remote medical services for patients. Operates as a telemedicine platform for online consultations, follow-up visits, prescriptions, and remote specialist access through a dedicated mobile app and WeChat platform.
• Multi-Disciplinary Treatment / MDT (多学科诊疗) Multi-disciplinary treatment approach combining expertise from multiple medical specialties for complex cases. Coordinates cross-specialty teams to deliver integrated diagnosis and treatment planning for complex and rare diseases.
• International Medical Services (国际医疗) International medical services division providing care for foreign nationals, international patients, and medical tourism with differentiated pricing and multilingual support.
• Rare Disease Diagnosis and Treatment (罕见病诊疗) Specialized diagnosis and treatment services for rare diseases, providing expertise and multidisciplinary care for patients with uncommon medical conditions.
• Online Appointment Registration (预约挂号) Online appointment registration system for outpatient services across all hospital departments, accessible via the hospital website, WeChat service account, and Beijing unified platform (114/京医通).
• Da Vinci Robotic-Assisted Surgery (达芬奇机器人手术) Robotic-assisted minimally invasive surgery using two da Vinci Xi systems for urological oncology (kidney cancer with IVC tumor thrombus, prostate cancer, bladder cancer), cardiac surgery, and thoracic surgery. Urology department ranked top 3 in Beijing by robotic surgery volume since 2020.
• Transperineal Prostate Biopsy (经会阴前列腺穿刺活检) Transperineal prostate biopsy technique providing safe, accurate, and painless diagnosis of prostate cancer with reduced infection risk compared to traditional approaches.
• Painless Cystoscopy (无痛膀胱镜) Painless cystoscopy examination performed under anesthesia for improved patient comfort during urological diagnostic procedures.
• Prostate Laser Enucleation (HoLEP/ThuLEP) Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP) for benign prostatic hyperplasia treatment, using the proprietary Seven-Step Two-Lobe technique and Canopy Technique for apex preservation.
• Patient Privacy and Security Services (隐私安全服务) Privacy and security services for online patient information including identity verification and password protection for medical report inquiries.
• Laboratory Test Results Inquiry (检验查询) Laboratory test results inquiry service available through the patient portal for outpatient and inpatient diagnostic reports.
• Examination Results Inquiry (检查查询) Medical examination results inquiry service (CT, MRI, ultrasound, etc.) available through the patient portal.
• Drug Information Query (药品查询) Drug information query service available through patient portal for prescribed medications.

Quantifiable outcome

• Kidney cancer IVC tumor thrombus surgery: 0% perioperative mortality (reduced from ~15%), severe adverse events 0.5% (reduced from 30%), average postoperative stay reduced from 14 to 8 days
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

14 partnerships are on record, tiered core, minor and major.

• Evangelos Liatsikos (ESU President, Greece)coreStrategic or Co-development Partner · 1 November 2025ESU President visited and exchanged on kidney cancer thrombus treatment, domestic robot applications, remote robotic surgery, and stone management. Agreed on international academic conferences, cross-border physician training, remote robotic surgery collaboration, multi-center research, and young physician exchange.
• Laser Application Regional Demonstration Center (工信部/卫健委激光应用区域示范中心)minorStrategic or Co-development Partner · 1 November 2025Ministry of Industry and Information Technology / National Health Commission designated laser application regional demonstration center, focusing on blue laser vaporization surgery training and promotion.
• Arnulf Stenzl (EAU Secretary General, Germany)coreStrategic or Co-development Partner · 1 September 2025International academic exchange on urological tumor comprehensive treatment. Professor Stenzl, EAU Secretary General, visited and gave lectures on upper tract urothelial carcinoma treatment. Discussed future cooperation in clinical trials, translational research, and young physician training.
• Jiangsu fenx Medical Technology (精锋医疗)coreTechnology or Integration · 1 April 2025Partnership for domestic surgical robot development and remote surgery applications. Collaboration established remote medical and internet medicine center, robotic surgery demonstration and training center, and medical-engineering translational medicine institute. The department conducted remote robotic surgery demonstrations using the Jingfeng domestic robot.
• Beijing Medical Innovation Research Institute (北京大学临床医学高等研究院)coreStrategic or Co-development Partner · 1 April 2025Joint application for 'Beijing Key Laboratory of Medical Engineering Cross-Border Innovation for Malignant Tumors' approved as a municipal key laboratory. Focus on medical-engineering integration and translational research.
• Martini KLINIK (Germany)coreStrategic or Co-development Partner · 1 April 2025Germany's largest prostate cancer treatment center (2,600+ radical prostatectomies annually). Professor Markus Graefen visited the department. Mutual academic exchange, multi-center clinical research, and training collaboration established. Professor Graefen highly praised the department's achievements in complex tumor surgery.
• Zhongshan Hospital Affiliated to Fudan University (中山大学附属第一医院)majorStrategic or Co-development Partner · 1 April 2025Dual-city surgery broadcast collaboration in April 2025. Two centers demonstrated robotic and laparoscopic urological surgeries. Joint academic exchange on kidney cancer, bladder cancer, and prostate cancer treatment techniques.
• Beijing Integration Medicine Society — Urology Branch (北京整合医学学会泌尿外科分会)majorStrategic or Co-development Partner · 1 January 2025Department serves as president unit of the Beijing Integration Medicine Society Urology Branch. Organized second annual meeting in January 2025 with 13 sub-forums focusing on integrated approaches to urology disease treatment.
• China-Urology Medical Consortium (泌尿外科临床科研医联体)majorStrategic or Co-development Partner · 1 January 2025Established clinical research medical consortium for urology. 24th consortium meeting held in 2024 with case studies and training for member hospitals. Aimed at standardizing diagnosis and treatment across member institutions.
• Shanghai Jiao Tong University Affiliated Renji Hospital (上海交通大学附属仁济医院)majorStrategic or Co-development Partner · 1 November 2024Joint dual-city surgery broadcast event in November 2024. Completed 14 joint minimally invasive urological surgeries including robotic and laparoscopic tumor resections. Continued collaboration for technical exchange and joint training.
• ASKLEPIOS Hospital (Germany) — invitation for visiting professorshipmajorStrategic or Co-development Partner · 1 September 2024Professor Zhang Shudong and Professor Zhang Fan invited as visiting professors to ASKLEPIOS Hospital in Germany. Participated in German urology robotic surgery annual meeting with surgical demonstrations and keynote speeches.
• Beihang University (北方院校泌尿外科 — no formal partnership name)coreStrategic or Co-development Partner · 1 September 2024500th robotic surgery milestone celebrated with Beihang Campus leadership. Strong operational integration with Beihang Campus urology department, including shared robotic surgery platform.
• Ruben De Groote (Belgium OLV Hospital)coreStrategic or Co-development Partner · 1 April 2024Online academic exchange on kidney cancer with venous thrombus treatment innovation and international collaboration. Discussed delayed IVC blocking technique application in Belgium. Agreed on evidence-based surgery innovation sharing and international cooperation.
• 100+ member hospitals medical consortium (医联体)majorChannel Partner/ Reseller/ Distributor · 1 January 2023Established urology specialized medical consortium with 100+ member hospitals in 20+ provinces. Runs regular consortium meetings, surgical review sessions, and training programs for member institutions. Bidirectional referral pathway established.

Scale indicators11 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• The First Affiliated Hospital of Zhejiang University: Top-ranked Zhejiang University-affiliated tertiary academic medical center. Comparable profile as a comprehensive public teaching hospital with high surgical volume and research output; serves as an east-China peer benchmark for ranking, robotic surgery adoption, and complex case throughput.
• Huashan Hospital, Fudan University: Top-ranked Shanghai tertiary academic medical center affiliated with Fudan University. Comparable as a top-tier Chinese public academic hospital competing for national complex referrals, surgical talent, and high-impact research publications, though regional to Shanghai.
• Zhongshan Hospital, Fudan University: Major Shanghai tertiary academic medical center and dual-city surgical broadcast partner of Peking University Third Hospital. Directly comparable in urological and cardiovascular surgery capabilities and academic standing — explicit broadcast collaboration referenced in the data.
• West China Hospital, Sichuan University: Largest tertiary academic hospital in western China, consistently top-ranked nationally. Comparable as a university-affiliated top-tier public hospital with comprehensive specialty coverage, high surgical volume, and strong clinical research output — but operating in a different geographic market.

Direct peers

• China-Japan Friendship Hospital: Large Beijing tertiary public hospital with broad specialty coverage and significant surgical volume. Comparable as a public tertiary academic medical center in Beijing competing for the same patient pool, surgeon talent, and clinical technology training designations.
• Peking Union Medical College Hospital (PUMCH): Beijing's flagship tertiary academic medical center, also affiliated with Peking University/Chinese Academy of Medical Sciences. Comparable as a top-tier comprehensive public academic hospital competing for the same complex referrals, physician talent, and national Clinical Key Specialty status in Beijing.
• Beijing Tiantan Hospital (Capital Medical University): Capital Medical University-affiliated tertiary hospital in Beijing and a national leader in neurosurgery and neurology. Peer in the same top-tier Beijing public academic hospital class, competing for complex referrals, residency training talent, and high-impact clinical research.
• Beijing Chaoyang Hospital (Capital Medical University): Beijing tertiary hospital affiliated with Capital Medical University providing comprehensive specialty care. Competes with the subject hospital for the same Beijing patient pool, surgical talent, and complex referral volumes.

Emerging players

• Renji Hospital, Shanghai Jiao Tong University: Major Shanghai tertiary hospital and dual-city surgical broadcast partner. Comparable in minimally invasive urological surgery programs and academic collaboration — actively partnered with the subject hospital for live surgical demonstration events.

Regional players

• Martini KLINIK (Germany): Germany's largest prostate cancer treatment center (2,600+ radical prostatectomies annually). Direct international academic partner and benchmark for urological oncology excellence — relevant peer for surgical technique, robotic surgery protocols, and clinical research collaboration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%8C%97%E4%BA%AC%E5%A4%A7%E5%AD%A6%E7%AC%AC%E4%B8%89%E5%8C%BB%E9%99%A2

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 北京大学第三医院